August 2026
Added to Dediabetes Aug 22, 2026RCTs
This study evaluated the effects of a hybrid closed-loop insulin delivery system on cognitive function in adolescents with Type 1 diabetes, finding significant improvements in several brain metrics.
Interventions
Hybrid closed-loop systemStandard treatment
Outcomes
Cortical surface area improvementCortical thickness (Co.Th)Improvement in Fractional Anisotropy+4 more
Added to Dediabetes Aug 22, 2026RCTs
This study investigated the effectiveness of hybrid closed-loop insulin delivery compared to standard insulin therapy in youth with type 1 diabetes, finding improved glycemic control.
Interventions
Hybrid closed-loop systemInsulin therapy
Outcomes
Diabetic ketoacidosisFasting C-peptide levelsHbA1c+2 more
Added to Dediabetes Aug 22, 2026RCTs
The study investigated the effects of closed-loop insulin delivery on hypoglycemia in women with Type 1 diabetes postpartum, finding reduced hypoglycemia with this method.
Interventions
Hybrid closed-loop systemInsulin pump
Outcomes
Diabetic ketoacidosisPercentage of time spent above 180 mg/dLPercentage of time spent below 70 mg/dL+3 more
Added to Dediabetes Aug 22, 2026RCTs
This study evaluated the impact of CamAPS FX hybrid closed-loop insulin delivery on caregivers of very young children with Type 1 Diabetes, finding significant improvements in caregiver well-being and reduced fear of hypoglycemia.
Interventions
Hybrid closed-loop system
Outcomes
HFS Behavior Subscale ScoreHFS-worry subscale scoreImprovement in Well-Being+1 more
Added to Dediabetes Aug 22, 2026RCTs
This study analyzed the effects of ultra-rapid insulin in a hybrid closed-loop system, finding that Fiasp resulted in greater glucose reduction compared to insulin aspart.
Interventions
FiaspInsulin LisproInsulin aspart+1 more
Outcomes
Glucose reduction 120 minutes after Boost initializationMean glucose on Boost initialization
Added to Dediabetes Aug 22, 2026Non Randomized CT
This study evaluated the DiaRem scoring system's sensitivity in predicting diabetes resolution post-bariatric surgery in morbidly obese patients.
Interventions
Bariatric surgery
Outcomes
Distribution of DiaRem scores among patientsFasting blood sugar (FBS)HbA1c
Added to Dediabetes Aug 22, 2026RCTs
This study evaluated the effectiveness of the Endobarrier for obesity and type 2 diabetes treatment, finding greater weight loss compared to lifestyle modifications alone.
Interventions
Endobarrier insertionLifestyle intervention for prediabetes
Outcomes
Food preferenceTotal daily caloric intakeWeight loss dependent effect on HbA1c
Added to Dediabetes Aug 22, 2026RCTs
The study investigated the hormonal adaptations following Roux-en-Y gastric bypass (RYGB) in patients with type 2 diabetes, revealing significant hormonal changes.
Interventions
Gastric bypass
Outcomes
Adrenocorticotropic hormone (ACTH) levels following RYGBGLP-1Glucagon+5 more
Added to Dediabetes Aug 22, 2026RCTs
This study compared Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) regarding their effects on bone health in patients with type 2 diabetes, finding significant differences in bone mineral density and biochemical markers.
Interventions
Gastric bypassSleeve gastrectomy
Outcomes
Bone mineral density (BMD)Change in Areal Bone Mineral Density at Lumbar SpineChange in Areal Bone Mineral Density at Total Hip+2 more
Added to Dediabetes Aug 22, 2026RCTs
Bariatric surgery, specifically gastric bypass and sleeve gastrectomy, improved beta-cell function in obese patients with type 2 diabetes.
Interventions
Gastric bypassSleeve gastrectomy
Outcomes
Acute insulin response after SIITDisposition IndexFasting Plasma Glucose (FPG)+2 more